Aiea, Hawaii
Cardax Pharmaceuticals is developing proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles – including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company’s proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity.
Website